Zurcher Kantonalbank (Zurich Cantonalbank) Stoke Therapeutics, Inc. Transaction History
Zurcher Kantonalbank (Zurich Cantonalbank)
- $39 Billion
- Q2 2025
A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Stoke Therapeutics, Inc. stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 9,129 shares of STOK stock, worth $249,312. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,129
Previous 9,129
-0.0%
Holding current value
$249,312
Previous $60,000
71.67%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding STOK
# of Institutions
139Shares Held
58MCall Options Held
2.7KPut Options Held
57.4K-
Black Rock Inc. New York, NY5.41MShares$148 Million0.0% of portfolio
-
Lynx1 Capital Management LP San Juan, PR5.4MShares$148 Million18.16% of portfolio
-
Rtw Investments, LP New York, NY5.12MShares$140 Million0.89% of portfolio
-
Baker Bros. Advisors LP New York, NY4.63MShares$127 Million0.53% of portfolio
-
Redmile Group, LLC San Francisco, CA4.38MShares$120 Million6.04% of portfolio
About Stoke Therapeutics, Inc.
- Ticker STOK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,419,300
- Market Cap $1.08B
- Description
- Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...